Akorn Exits Chapter 11 Protection After Completing Sale to Lenders
Akorn, a specialty pharmaceutical company, completed its sale to its term loan lenders and exited Chapter 11 protection.
October 2, 2020
Akorn | Doug Boothe
AlixPartners, PJT Advise Akorn During Chapter 11 Process
AlixPartners is serving as restructuring advisor, PJT Partners is serving as financial advisor and Kirkland & Ellis is serving as legal advisor to Akorn, which filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code.
May 22, 2020
JPMorgan Agents Akorn $750MM Financing Agreement
Akorn entered into a $600 million term loan and up to $150 million of a revolver. JPMorgan served as administrative agent for both facilities. The financing supports Akorn’s acquisition of Hi-Tech.
April 24, 2014
JPMorgan to Finance Hi-Tech Pharmacal Sale to Akorn
Akorn and Hi-Tech Pharmacal entered into a definitive agreement under which Akorn will acquire Hi-Tech for $640 million in cash. JPMorgan committed the credit agreement consisting of a $600 million term loan and a $75 million revolver.
August 29, 2013